outlook bullish space upgrad
mo pm buy jt hold
bullish tobacco upgrad mo pm buy jt
hold underli sector tsr expect vs wider large-cap
stapl less demand valuat discount stapl recent
high return driven solid ebitda sizeabl re-rat increas rrp
convict reflect us ct benefit eas regulatori concern yield
also see possibl large-scal ad upsid
bullish sector see underli sector tsr vs wider large-cap
stapl less demand valuat discount stapl recent high
return driven solid ebitda increas reduc risk scale cost save deal synergi
recoveri recent price weak sizabl re-rat increas convict around
reduc risk reflect us ct benefit eas regulatori concern yield close
return outlook rel valuat also limit downsid risk rise yield
vs seen recent past around trump elect vs wider stapl
also see possibl large-scal jt imperi bid ad upsid
updat estim captur fx us tax reform rise bond yield
administr bat stay top pick despit downgrad fx best long-
term growth prospect valuat remain appeal prefer mo pm
model tsr name upgrad buy return
driven strong earn deliveri support ct reform mo pm fx pm
expect re-rat still cautiou jt big chanc de-rat view
fx support see us upgrad hold imperi neg earn expect
bring underli valuat gbp would typic warrant
hold see jt bid increas possibl factor chanc
number take pt gbp remain buy
industri theme catalyst sector sentiment rrp segment
develop market need confid around input growth drive re-rat also
import possibl imb/jt mo/pm reduc risk increas bond yield pt
sensit rate rise vari shift fx jt pm see
larg support year headwind industrywid catalyst includ us ct guidanc
suggest yet fulli price especi mo also sector-wid consider
increas invest anprm nicotin us downsid like buy
dip canadian litig concern overdon caus anxieti especi bat
possibl heat tobacco approv us big upsid potenti first market
stock specif catalyst bat evid rrp competit includ grow
contribut number acceler share gain us import
imb focu sign price weak persist evid on-going
share gain sign traction vapour launch jt fear part
growth expect high compani guidanc year key watch
possibl downgrad drive larg de-rat mo focu whether
compani arrest recent share declin marlboro pm tpsac review iqo
next week could trigger strong re-rat recent pressur
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
tabl content
underli tsr expect driven re-rat attract yield
rate reflect sector bullish mo pm move buy jt hold
chang pass exactli
altria see biggest support earn potenti
bewar number way set stone
benefit necessarili fall bottom line
develop rrp segment global key sector re-rat
rrp trend approv us templat global develop
scientif studi rrp import deliv segment buy-in
combust price even import given increas invest
possibl larg scale like other
imperi bid like jt increas possibl
expect see move reduc risk keep eye juul
bolt on combust less common make less sens
cover pm mo combin
increas bond yield tobacco less vulner wider consum
three rate rise expect
concern warrant tobacco heavili impact post trump elect
tobacco less risk vs wider stapl view
run sensit rate rise
fx tide turn pm jt see support
us tax reform guidanc import sizeabl upsid potenti mo
guidanc implic earn rate
appar upsid earn estim money re-invest
impact rate like differ depend name
expect timelin guidanc tax impact usag
anprm us like neg buy dip
updat nicotin reduct plan key watch-out
expect anprm issu end februari latest
expect earli neg reaction despit well flag
way sector see support buy dip
look reaction imb bat
heat tobacco approv us larg gain possibl first market
potenti valu creation first market huge
stand applic
timelin potenti favour bat given rout taken
current expect approv market view
altria perhap downsid risk first
court decis canadian litig relev bat
on-going canadian litig concern amongst investor
outcom could day equal may
expect smaller fine manag like view
like share price reaction
bat potenti gain favour result
watch movement imperi
bat focu evid reduc risk contribut
evid contribut reduc risk global
evid lorillard synergi us
reynold synergi possibl upgrad fulli integr
imb recoveri price reduc risk move main watch-out
recoveri price key market question mark
on-going share gain crucial investor sentiment
traction newli launch product within reduc risk space
jt guidanc traction ploom
commit medium term model
sign regain share ploom japan
recoveri russia especi regard price
page
pleas see import disclosur inform page report
mo marlboro perform key focu
perform marlboro difficult background
detail around licens agreement pm iqo
pm evid slow-down rrp contribut
tpsac review like support
slowdown rate rrp contribut could disappoint
continu pressur underli combust busi
reduc risk percept drive sector rate
bat still attract despit recent strength
imb significantli under-valued lack catalyst
jt still yet fulli reflect go pressur despit think
mo multipl yet appear reflect us ct benefit
pm could vulner premium still inflat
page
pleas see import disclosur inform page report
bullish tobacco move reflect upgrad mo pm
buy jt hold see month underli sector tsr vs wider larg
cap stapl sector valuat much less demand
discount wider stapl near recent high
return outlook rel valuat also limit downsid risk rise yield
vs seen recent past around trump elect vs wider stapl
also see possibl larg scale jt imperi bid ad upsid
underli tsr expect driven re-rat attract yield
breakdown expect stock specif sector averag tsr shown chart
ebitda contribut strong increas scale reduc risk cost save
deal synergi bat support also expect industri combust price
recov somewhat vs weak seen last coupl year remain robust
case bat forward month number strong ebitda
contribut reflect lap outlin addit invest
expect see sector re-rat year on-going us corpor tax
benefit price concern around fda regul fade away post advanc
notic propos rulemak market get convict around
mo pm addit catch ct benefit possibl gain
greatest name strong month impli re-rat also reflect
mo assum spend behind iqo roll pm
assum sharp move toward tax pariti reduc risk reduc risk tax
environ remain rel support howev sentiment around
unlik impact near-term multipl
believ current multipl expect reflect assum heat
tobacco approv us assum approv year end/earli
possibl could come soon approv come
multipl get boost
expect dividend yield attract high end recent histor
chart breakdown expect tsr across global tobacco
note base chang equiti valu vs share price multipl
chang reflect ev/ebitda also reflect month forward number
chart averag trail dividend yield global
tobacco time
page
pleas see import disclosur inform page report
rate reflect sector bullish mo pm move buy jt hold
sector rate heavili skew buy four buy bat imb exist buy
upgrad mo pm buy hold one hold jt upgrad
even case jt one could make valid case buy given possibl
bid imperi could accret although believ de-rat
occur bid potenti happen dont includ scenario
difficult predict deal might structur market would view
asset would divest
summaris price target rate earn estim vs consensu near
term growth expect key valuat metric across coverag name
chart detail/discuss around growth valuat provid later
note
chart summari rate growth expect
note jt ep estim shown basic report ep estim vs number dilut adjust reason show
basic report allow better comparison consensu likewis imb ep shown basic adjust front page
show dilut adjust differ comparison consensu estim dilut adjust
chart summari key valuat metric
prefer tobacco amongst wider stapl expect tsr
compar consensu expect wider larg cap stapl chart
tobacco current valuat less demand chart discount wider stapl
near recent high misplac concern around fda regul growth
new tobacco model drive sharp sell
page
pleas see import disclosur inform page report
note tobacco number jefferi estim larg cap stapl consensu
note consensu number
page
pleas see import disclosur inform page report
 posit favour bat mo pm buy
term posit would want name benefit
corpor tax reform well place competit reduc risk
criteria point bat mo pm mo pm move buy hold
point imb jt see pressur consider summaris
detail stock specif invest thesi ration rate
chang tabl follow
bat buy would top pick given attract valuat catalyst risk
skew upsid
would favour mo buy believ sizeabl upsid corpor
tax benefit yet price like invest part tax windfal
help eas market share pressur see
pm buy expect return base price target similar
bat mo gain driven corpor tax fx re-rat
approach name slightli caution still see multipl potenti
vulner valuat much less challeng year ago
rel premium still high end recent rang although justifi
view given reduc risk exposur
less posit imb buy neg jt hold name
trail reduc risk see level support us corpor tax
reform also set anoth year miss medium-term growth
despit subdu outlook imb remain buy believ bid
name like jt next month increas possibl
factor chanc happen price target
although upgrad jt hold under-perform driven fx
still see strong chanc de-rat year point bid imb
risk neg jt sizeabl accret could realis still
expect see downsid howev happen
page
pleas see import disclosur inform page report
mo thesisalthough concern longer term tricki spot growth reduc risk relianc iqo would expect strong perform next month sizeabl potenti corpor tax benefit current appear price ahead consensu like addit invest fund tax windfal also help arrest pressur seen toward back end year marlboro lost share amidst higher price down-trad competit bat also global growth heat tobacco expect cotninu along studi releas favour health benefit think multipl see increas credit option valu around iqo valuat also unchalleng rel past market price recent marlboro pressur see month tsr upgrad buy main risk thesi see competitor heat tobacco approv ahead iqo product licens pm although dont see approv bat thesisw believ bat set peer best growth long term strongest cigarett ex us brand portfolio continu take share on-going cost save support ad attract us cigarett busi price potenti signific still larg synergi lorillard deal fda regul wont impact near term potenti take lead posit reduc risk wide rang product full control world largest vapour market current valuat also way reflect growth outlook key barrier multipl support lack convict reduc risk busi expect uncertainti fade away reduc risk sale contribut increas support addit invest outlin us corpor tax benefit support multipl also come anprm us way hope decis canadian litig commun bat top pick model month tsr risk thesi advers conclus litig canada competitor heat tobacco approv ahead us although dont see approv consum
page
pleas see import disclosur inform page report
pm thesi cautiou pm felt multipl gotten ahead concern around increas reduc risk tax especi japan korea would may move multipl come manag level much certainti reduc risk tax outlook key market next month remain rel support fx benefit year headwind given recent shift nois around heat tobacco likley help growth studi support health benefit fda tpsac reveiw iqo help address concern applic irregular rais recent reuter report earn upgrad like ahead consensu tax benenfit fx reflect much confid around near term perform month tsr expect upgrad buy risk thesi neg press like reuter articl end year sizeabl slowdown reduc risk contribut sale surpris tax increas competitor activ weigh worsen combust perform imb thesiswhil believ long term model deliv sustain sizeabl re-rat expect becom evid market unlik give credit time soon especi given heavili weight expect earn deliveri recent administr increas invest peer upon copor tax benefit unfavour fx like earn downgrad consensu bring underli valuat gbp reflect recent updat lower exit mutipl captur likley sentiment despit near term fundament pressur remain buy see bid imperi likley jt increas possibl factor chanc materialis valuat new pt gbp risk thesi jt anoth deal rule imperi bid arguabl bid premium still name us invest peer result significantli pressur price market group ebit jt thesisgiven current structur pressur unless compani deal zero chanc hit long term growth target view valuat current reflect outlook market seemingli price return model near term move next year pressur persist would expect de-rat fx support earn upgrad howev requir move hold under-perform expect tsr move posit vs neg previous risk thesi ploom surpris us late roll inferior product view take back sizeabl share japan jt bid imperi come sooner expect would accret consum
 detail breakdown estim pt chang
sinc last updat number develop includ movement
fx administr corpor tax reform us rise bond yield
updat estim price target reflect chang chart
summaris adjust name
chart summari chang earn estim pt bat
chart summari chang earn estim pt imb
chart summari chang earn estim pt jt
page
pleas see import disclosur inform page report
gbp gbp prior benefit us corpor tax reform ct spend per bat guidanc invest ct benefit back busi includ invest combust reduc risk larg skew reduc risk better price reflect move cigarett tax pariti slower model tweak near term longer term oper assumpt mainli reflect chang japan price captur recent estim fx headwind oper profit year vs previous repres impact role forward model one year rf risk free rate captur increas bond yield new epsptcommentsjpi jpi prior peer ramp invest support us corpor tax reform assum jt also increas near term spend order attempt keep pace japan chang captur recent reform estim fx tailwind oper profit year vs dividend pay-out estim repres impact role forward model one year rf risk free rate captur increas bond yield new epsptcommentsgbp gbp prior benefit us corpor tax adminstr imperi guid tweak near term long term oper assumpt main chang weaker near term price estim us due increas invest mo estim fx headwind oper profit year vs previous repres impact role forward model one year rf risk free rate captur increas bond yield exit increas invest peer reduc risk fund corpor tax limit traction space plu industri price weak like us bring year exit multipl new estim assum bid gbp epsptimbcom consum
chart summari chang earn estim pt mo
chart summari chang earn estim pt pm
page
pleas see import disclosur inform page report
usd usd prior benefit us corpor tax reform ct spend part tax benefit invest back form price op ex tweak near term long term oper assumpt larg reflect better share trend back increas chang abi valu rel consensu pt roll repres impact role forward model one year rf risk free rate captur increas bond yield new epsptcommentsusd usd prior benefit us corpor tax reform rrp assum greater price move cigarett tax pariti slower model model greater increment spend next year tweak near term longer term oper assumpt mainli reflect chang japan price captur recent estim fx tailwind oper profit year vs previous roll repres impact role forward model one year rf risk free rate captur increas bond yield new epsptcom consum
detail us corpor tax reform
one key assumpt includ estim updat possibl
impact us corpor tax reform provid detail around reform
possibl earn support possibl use fund
chang pass exactli
key part us tax reform could impact global tobacco coverag includ
corpor tax rate reduc start
interest tax deduct deduct net interest expens ebitda
four year ebit thereaft
capit invest allow full immedi expens short-liv capit
invest five year
altria see biggest support earn potenti
estim potenti support earn across coverag name
chart includ assum chang group tax rate note jt see
benefit reform us make less ebit impact
immateri show case bat imb number actual
support alreadi guid impact
chart breakdown expect impact us corpor tax chang
note bat imb figur actual guid alreadi imb show two number
figur bracket repres get full year support
bewar number way set stone
one thing keen flag highli like actual benefit differ
number calcul name guid alreadi
assess impact chang headlin rate quit simpl
becom tricki regard offset interest expens etc privi
current structur also case imperi one need factor impact
current offset amortis acquir goodwil
although actual support like differ number confid
wont dissimilar therefor appli updat estim justifi
benefit necessarili fall bottom line
name see support corpor tax think see
benefit fall bottom line especi given invest demand around
develop rel embryon reduc risk categori ensur competit
new emerg segment exist combust busi saw
bat indic re-invest entir benefit imperi
appear let benefit fall bottom line howev shown tabl
amount small larger may made differ
page
pleas see import disclosur inform page report
number overrid theme drive sentiment investor confid
space next month
us stand topic/focu reduc risk segment evolv
investor look gain confidence/certainti around new tobacco model
look like name valu lie
potenti larg scale increas yield give sector proxi govern
bond swing fx also like key consider
develop rrp segment global key sector re-rat
becom clear last month tobacco model past
chang move one domin cigarett one ultim
potenti domin reduc risk product
new tobacco model look like sort growth deliv creat
much uncertainti current weigh sector multipl extent tobacco
discount global consum approach recent high chart rang across
sector multipl chart greater long time seen
reduc risk leader see sizeabl support seen loser see rate
note consensu number
chart histor ntm consensu pe across global
note multipl diverg begin reduc risk
start get attent
given uncertainti around new model reduc risk categori develop
compani lead way growth profit deliveri look like
key watch-out
market get comfort around number area concern/uncertainti
believ sector whole see re-rat ultim conclud recent
note think new tobacco model could see sector trade high
multipl futur variou input prove
categori evolv market abl form better idea
perceiv segment valu alloc amongst player possibl
drive rang valuat even greater
page
pleas see import disclosur inform page report
area focu includ
product format drive growth still consensu around
sub-seg reduc risk winner heat tobacco vapour
even within product format prove popular carbon
tip devic base within heat tobacco numer format within
sub-seg heat tobacco vapour drive growth
import implic sector valuat regard compani
posit also pure econom bat recent guid sale
four time accret heat tobacco vapour
differ heat tobacco vapour econom perhap one
reason bat yet get credit reduc risk busi pm
bat say futur growth domin vapour wherea pm say
domin heat tobacco
tax structur evolv moment vast major market
reduc risk enjoy tax advantag cigarett evolv also
import implic segment valu expect see
market implement aggress tax reduc risk year
major market implement larger tax could weigh sector valuat key
watch-out pend legisl propos eu plan tax
vapour expect one would assum must forthcom
good data sourc current tax rate date news around
propos vapourproductstax websit http //vaporproductstax com/
market share trend space domin big tobacco
would suggest number one concern amongst investor speak
shift new model whether space continu domin
major investor point success compani call juul us
taken market share year evid perhap might
case
big tobacco invest even greater amount space
addit roll new improv product get much better
insight whether non-big tobacco fear justifi could also feasibl
see scenario big tobacco buy competit like see
within big tobacco also get much clearer idea like
on-going winner see name go
big invest across number market
start see total tobacco volum growth holi grail reduc
risk term near term growth also termin growth rate therefor
justifi valuat gener total tobacco volum growth least
declin less neg see current potenti
sourc support volum close observ usag day
non-smok penetr
usag day argument suggest smoker
switch consum day less concern kill oneself
happi use around friend famili possibl
use indoor public place although technic allow
see mani peopl vape pub without anyth said
regard non-smok penetr alreadi
encourag sign respect bat recent say
vapour user uk never smoke data around
market could signific
remind sensit around variou input growth could look
like differ scenario therein lie uncertainti would refer reader
work recent note
page
pleas see import disclosur inform page report
rrp trend approv us templat global develop
much tie theme global develop rrp categori
event us specif possibl approv launch heat tobacco
us world largest reduc risk market global reduc risk sale
vs cigarett like use templat global categori
growth assumpt dynam
us market even spotlight heat tobacco approv
full rang product across format compet scale
seen anywher els us also import one market
share data reliabl track
scientif studi rrp import deliv segment buy-in
notabl road block present view around consum investor regul
buy-in reduc risk world lack conclus studi around reduc risk
claim major studi conduct date fund big
tobacco extent suspicion safeti claim product recent
worsen reuter headlin decemb report irregular test
carri pm submiss fda
would expect studi space releas throughout
year could prove import sector view importantli
studi agre lower risk claim big tobacco doubt
posit catalyst likewis question claim could weigh
studi know watch result german risk
institut assess iqo expect also on-going work smoke
free foundat http //www smokefreeworld org/ result extens user
percept studi research prioriti expect outlin march although
question foundat independ unfair view given fund
combust price even import given increas invest
signific headwind across space combust price weak
across number key market alway seen price skirmish concern
amongst investor potenti enter phase becom
much common especi given also saw slowdown histor
price rang becom accustom suddenli look like
import price arguabl becom even relev next coupl
year given need fund invest reduc risk roll spend
expect signific expect reduc risk op ex spend across
name sale shown chart without support combust
price near term profit deliveri could weaken volatil
mind headwind import price fund
invest trend doubt close follow sign weak
key market could see sector de-rat
recent price expect go forward seen chart current
model price return level still level past
page
pleas see import disclosur inform page report
chart estim total op ex spend sale across
coverag name
chart recent expect industri combust
possibl larg scale like other
 consider tobacco view split larg scale
bolt-on reduc risk bolt-on combust depend
carri would question whether right use fund today
imperi bid like jt increas possibl
see jt bid imperi increas possibl us star align
imperi rel valuat cheaper ever sustain jt
model question first time imperi tick number strateg box
jt new ceo whose background heavili focus past within
know week imperi trade comment new jt ceo
januari focus smaller emerg market deal asia
would take pinch salt number reason
jt continu claim interest cigarett us ever done
believ unlik read sec transcript around lorillard
deal third parti believ could jt express interest
divest asset
statement around emerg market deal contrast statement
interview took said activ pursu deal regardless
size say scale matter emerg deal scale
would issu
sharehold would question use capit strateg ration deal
emerg market combust moment see section emerg
growth reduc risk what compani still deal
combust focus middl east africa vs asia
view jt want infrastructur middl east africa imperi best way
opinion best posit region global
think imperi still prefer jt need find partner
easi respect found interest interview focus emerg
market deal ceo also said larg deal like face anti-trust issu think
difficult success complet deal alon
page
pleas see import disclosur inform page report
us number possibl partner still make feasibl bat
privat equiti china tobacco even option roll asset cant keep
ipo new compani
also possibl china tobacco jt could make bid imperi
report global ambit believ interest paper read around
et al releas call china nation tobacco corpor
domest global dragon
written detail jt/imperi combin includ look deal
econom coupl relev recent note found
background believ chanc bid next month
expect see move reduc risk keep eye juul
reduc risk becom increasingli import see wave small
acquisit big tobacco better posit space would expect
small reduc risk bolt-on continu
deal like remain small one possibl would keep eye
potenti juul number one player us bought someon acquir
like suitor would imperi jt view given pressur
multipl see present due lack reduc risk competit
whether bought compani outright think jt could afford acquir
stake enter partnership juul expand global struggl without
distribut would doubt seen posit market although may
implic jt bid imperi materialis
term possibl valuat juul look us could easili warrant
valuat around usd start factor global ambit
valuat excess usd could argu
bolt on combust less common make less sens
new growth opportun reduc risk vs emerg market combust
old model mind think smaller bolt deal combust
becom less common extent recent discuss pm said would
complet commit smoke free world went
emerg market deal combust
emerg combust deal set becom less common would also question
strateg ration occur mani emerg market asian lat
industri volum fallen cliff mani market wors develop due
illicit suscept aggress tax increas shocker
region would fulli support deal would improv
infrastructur middl east africa primarili africa combust trend
cover pm mo combin
anoth large-scal deal often mute press pm mo
combin see ultim end game believ littl
chanc happen next month think pm make littl sens
share-hold valu creation multipl requir would huge would offer
littl accret due price paid fund would potenti limit
dividend buy-back polici would come lot risk distract
tri build reduc risk busi global basi also believ
combin happen quit contrarian mani reason discuss
would led pm would make sens mo buy pm
page
pleas see import disclosur inform page report
increas bond yield tobacco less vulner wider consum
theme like concern investor assess invest stapl tobacco
impact rise bond yield especi given bond like characterist
seen bond proxi concern warrant given happen
immedi aftermath trump elect expect three rate rise
current year see risk tobacco less previous also notabl less
risk pose wider stapl
three rate rise expect
per jefferi chief economist ward mccarthi us economi good place
growth profil continu improv would highlight market expect
rate increas
concern warrant tobacco heavili impact post trump elect
concern around sell stapl tobacco upon rate increas
warrant especi given bond like characterist also downsid saw
post trump elect bond yield expect start creep chart
sharp sell-off tobacco stapl multipl recov
econom realiti trump could actual implement time period
set
chart recent trend consensu ntm pe global consum wider
tobacco less risk vs wider stapl view
concern around de-rat upon rise yield warrant think risk
tobacco less rel wider consum back around trump elect
expect tsr project greater rememb vs
valuat also much less challeng discount wider stapl chart
vs trump elect use tobacco ex jt consensu
agre jt movement littl correl us yield much
close link trend domest market
support thesi seen rate movement tobacco vs wider stapl
upon rise us year yield januari chart wider
stapl de-rat tobacco saw gain nearli
page
pleas see import disclosur inform page report
chart tobacco ex jt discount wider larg cap
stapl around trump elect
chart rate movement tobacco ex jt wider
larg cap stapl around recent increas us yield
run sensit rate rise
new updat estim alreadi believ increas yield adequ
reflect increas risk free rate across space except jt
increas us name use risk-fre rate bat
exposur us use imperi exposur us use
jt immateri exposur name heavili link domest market vs
us use
believ rate rise adequ reflect also show sensit
increas rate chart see name greater debt
capit structur due leverag equiti valu emerg market exposur
due inflat differenti risk
chart estim impact increas risk free rate across
coverag name
fx tide turn pm jt see support
last year bat imb seen investor support due
right side fx jt pm punish fx weigh recent
shift exchang rate tide appear turn jt pm see sizeabl
support bat imb see headwind chang captur
new estim
page
pleas see import disclosur inform page report
addit certain theme impact across industri also specif
one event watch drive movement vari degre across
coverag name
import industri wide catalyst expect includ us ct reform advanc
notic propos rule-mak reduc nicotin decis canadian litig
possibl approv heat tobacco us
us tax reform guidanc import sizeabl upsid potenti mo
guidanc implic earn rate
name degre exposur us guidanc around us tax reform
import catalyst coupl reason firstli impact earn rel
alreadi price secondli rate impact depend fund
use decis around industri invest felt industri wide
good illustr two consider bat alreadi guid
tax impact use fund
releas date januari bat said tax reform would provid benefit
earn re-invest cash rrp develop
look bat share price movement around time major vote toward tax
reform would appear market alreadi price support
given appar support guidanc earn benefit would
invest back would lead one immedi conclud stock trade
case name finish day
make gain next two day
downsid earn perspect appear off-set
re-rat believ market took view addit invest
posit long term reduc risk posit multipl saw support
tri highlight need care predict share price
reaction upcom corpor tax guidanc possibl earn rate
impact need assess
appar upsid earn estim money re-invest
exclud bat imb alreadi guid show chart possibl tax
earn accret across coverag name ignor jt earn impact
immateri compar estim indic alreadi price
look share price movement around time major vote toward tax
pm mo see market appear yet factor full
estim roughli correct guidanc indic tax gain allow
fall bottom line see upsid name altria seemingli
gain
similarli either pm mo choos re-invest benefit per bat pure
earn basi could see downsid altria risk much
smaller degre upsid possibl
page
pleas see import disclosur inform page report
chart estim possibl earn support us ct reform
estim market alreadi price
note show two number pm number bracket support support reflect full
year given year end septemb
impact rate like differ depend name
seen bat assess possibl share price movement tax
guidanc also need factor potenti re-rat de-rat implic around
use tax fund think sentiment possibl rate movement like differ
depend stock look consider model spend
back across coverag name
bat like saw downgrad earn expect
off-set re-rat us make sens one reason view bat
trade discount pm lack convict reduc risk busi
indic therefor would invest larg part tax windfal back
busi primarili rrp taken posit market saw re-
pm think compani choos re-invest taken neg
market could see de-rat therefor assum money flow
need invest great bat view
alreadi credit multipl reduc risk one
secondli even bat addit outlin spend still
spend
thirdli need set asid invest roll
heat tobacco us get approv invest
burden fall altria
mind need pay debt resum buyback
current high pay-out ratio limit level possibl dividend
increas year think bottom line support tax benefit
expect market also current model money
support earn case think like view
altria given current pressur face marlboro on-going roll out
marlboro sku new sherman architectur benson hedg menthol
addit invest outlin bat believ market like
expect larg portion tax benefit re-invest
model altria re-invest larg portion money would expect
see de-rat
imb jt benefit tax reform immateri rate still
like see impact action peer invest outlin mo
pm addit bat alreadi guid like weigh multipl
biggest risk us regard jt pm guid action pm announc
invest assumpt part would go japan would expect
jt soft news
imb big watch-out mo set asid promot
invest pick us could make thing difficult imperi
page
pleas see import disclosur inform page report
expect timelin guidanc tax impact usag
would expect tax guidanc mo pm come year-end result
februari februari respect
anprm us like neg buy dip
updat nicotin reduct plan key watch-out
overwhelm neg catalyst impact space statement
releas fda juli consid lower nicotin level cigarett
non-addict level summaris two-day movement across space
chart would expect us expos name mo imb bat
one impact jt us exposur immateri
chart share price movement two day follow fda nicotin
announc juli
outlin part releas juli next step process potenti
lower nicotin releas advanc notic propos rule-mak
anprm anprm expect issu year extent includ
one fda key polici goal
anprm offici trigger process fact data gather determin
whether technic finic feasibl whether would support public health
would determin whether final rule implement
expect anprm issu end februari latest
know anprm issu point
specif would surpris hasnt come end februari given one
anprm e-liquid flavour alreadi issu decemb two
week fda polici goal outlin nicotin anprm
also part
expect earli neg reaction despit well flag
anprm well flag therefor argument made
non-ev think case expect see downsid
us expos name day issu coupl reason
firstli larg bulk investor tobacco specialist even mani
fulli awar juli releas still dont understand exactli fda tri
achiev like net posit backdrop
headlin alon around reduc nicotin like drive impuls
secondli convers mani misplac expect
around anprm consist help certain competitor note also
suggest get detail around specif refer saw
menthol anprm back
page
pleas see import disclosur inform page report
term actual learn non-ev view
anprm ask question around point order get view
product standard introduc period time nicotin
remov
product standard introduc level nicotin
reduc
product standard introduc focus nicotin yield
competitor note specul nicotin anprm includ
preliminari assess scientif evid along question
anprm note menthol anprm coincid publish
preliminari assess scienc menthol result expect
similar review scientif evid along question anprm
think reason expect extens review scienc
along anprm fda specif discuss
note part fda menthol review process tpsac report
menthol provid fda fda announc would
provid review scienc impact menthol cigarett peer
review panel scientif review peer comment would made
avail public comment complet total voluntari step
end two-year process
would also point fda juli announc indic
begin public dialogu lower nicotin level issu
anprm seek input lower nicotin level mention
anyth put review scientif evidenceso think
reason expect
quantifi like downsid would expect anywher near
saw juli would argu perhap maximum sell see
way sector see support buy dip
similar seen recoveri post juli announc would expect
see downsid anprm claw back balanc year would
urg investor buy dip therefor
support balanc year firstli come focu shift near term
fundament secondli believ larg number investor
reluct get back involv space way
look reaction imb bat
believ downsid recov focu name
reaction overli excess would argu opportun like imperi
bat view base saw juli weight share price reaction
time us cigarett exposur see reaction imb bat
way beyond movement seen mo chart
analysi suggest us market incorrectli appli neg assumpt
around us busi imb bat non-u part obviou mispric
would assum correct time
page
pleas see import disclosur inform page report
chart share price reaction fda announc weight us
heat tobacco approv us larg gain possibl first market
potenti valu creation first market huge
look themat implic heat tobacco approv us
also like possibl import catalyst impact perform individu
compani level player even heat tobacco approv pend
focu reaction like profound bat altria pm
reason current applic heat tobacco approv
us decis theori possibl sometim year
heat tobacco approv us see similar success japan
segment could worth around usd least therefor first market
would seen valu sizeabl advantag
stand applic
remind current two pend heat tobacco product applic
submit us first one iqo pm product mo
acquir right us sell distribut
pay licens fee pm second one core bat product
pm/mo two applic iqo mrtp modifi risk tobacco product
pmta pre-market tobacco approv mrtp file decemb
mrtp move scientif review may tpsac tobacco
product scientif advisori committe meet januari discuss
applic provid recommend fda time-frame
review pmi mrtp applic sole discret fda
issu non-bind guidanc intend review mrtp applic within
day post move scientif review
pmta file march regard pmta guidanc
seem bit concret say fda must act pmta promptli
possibl event later day receipt applic
defin move scientif review pmta move scientif review
bat gone differ approv rout submit two se
substanti equival one non-menthol juli anoth
menthol august commun around stage much vagu se
would assum also move scientif review let say end
october/novemb note ask compani
also could give definit answer fda plan take around day
review
page
pleas see import disclosur inform page report
timelin potenti favour bat given rout taken
theori given guidelin day post move scientif review pmta
day se pmta iqo could approv end feb se
core end jan/feb assum move scientif review end october/novemb
think approv time unlik coupl reason
polici fda goe back compani
inform clock stop given focu product leap
unknown fda highli unlik ask
inform fda want make sure decis complet water tight
approv product see time-frame extend
histor fda never stuck guid timelin one need look
backlog within cigarett se applic time-frame around swedish match
pmta applic snu case
argu one applic approv ahead would
say would bat reason regulatori pathway taken
short se approv simpli show fda product substanti
equival one market prior bat hope show core
substanti equival old reynold product revo requir
show product safer cigarett benefit public health
short pmta approv show product safer cigarett
mrtp show substanti safer cigarett show
substanti safeti commun product modifi risk
prove product safer se level document
requir much less burden proof time theori
much easier quicker fda review could also make case fda
would relax less comeback approv product
say safer therefor futur health complic aris could
accus labil
current expect approv market view
given factor current assum heat tobacco approv
make case se core bat applic get approv
think fda would reluct let one heat tobacco product market
anoth one still wait approv regardless fact gone differ
pathway especi given big focu area
current assumpt model approv product end
launch time start
worth also believ compani expect approv
guidanc like reflect also dont think market
expect happen year
mean howev approv come market move could
altria perhap downsid risk first
quantifi share price reaction bat pm altria almost imposs
idea around exact market assumpt present predict
whether posit neg move possibl extent move
rel peer
whoever first approv fda like see re-rat view
compani compani mo pm still applic pend like see
de-rat extent rate movement depend compani
page
pleas see import disclosur inform page report
bat see greatest upsid potenti first approv
number reason first think focu major valu us
approv current pm/mo function much pm/mo
spoken littl bat spoken second
domin player term us total tobacco market share present first
market could see dynam chang
neg side bat first approv downsid
expect extent altria reason given
also us market make ebit
altria see greatest downsid bat get market first face
number issu first huge focu iqo applic given
much pm/mo spoken second us mo profit third mo
around market share us mean alreadi face big hurdl
break even reduc risk world take least share
reduc risk space factor pm licens fee late market
make task lot difficult
posit side get approv first see upsid name
level bat also level potenti upsid may contain
hear term licens agreement pm see heat tobacco begin
take share especi given earli invest cost like sizeabl
pm doubt see de-rat iqo first approv
level seen bat especi altria view
get full access us econom anyway direct
busi us busi risk lost share total tobacco
sens flip side howev think support first approv
ahead altria option valu
requir front invest market doubt reward essenti
risk free access potenti sizeabl sourc new valu
even imperi jt dont heat tobacco applic pend
like share price implic sentiment around fact
competit heat tobacco like weigh also valuat
impact lost share heat tobacco cigarett exist vapour
product need consid
court decis canadian litig relev bat
on-going canadian litig concern amongst investor
final event close follow impact space outcom
litig canada directli impact bat jt pm could also potenti
indirectli impact day imb
remind happen part quebec class action big tobacco
compani order pay cad bat share cad pm
cad jt remaind defend appeal quebec court
appeal case heard novemb
outcom could day equal may
given year sinc appeal case wrap novemb
logic would tell decis year extent bat investor day
octob said point decis could day without
specif guidanc author howev remain big uncertainti equal
could delay back end even come term sentiment
around space support multipl sooner come way
expect smaller fine manag like view
tobacco compani said rang outcom possibl press
reluct say view
could although legal perspect us surmis full
page
pleas see import disclosur inform page report
damag upheld bat ultim pay full damag upheld bat
declar canadian subsidiari bankrupt damag upheld much reduc
amount case thrown view like outcom
damag upheld reduc amount given engl progeni preced us
fact believ govern want big tobacco compani declar
bankruptci like full damag upheld regardless scenario apart
case thrown request leav appeal suprem court appear highli
like share price reaction
damag upheld depend much pure valu term everi cad
damag translat roughli share price weak bat
pm jt although number would like overshoot due sentiment
around provinc win similar case bankruptci estim valu
bat canadian busi would equat neg reaction pm would
jt
bat potenti gain favour result
although name apart imperi exposur canada see
similar downsid upon bankruptci canadian subsidiari litig primarili
focu bat investor base convers probabl
explain fact greatest exposur full damag upheld paid
think unlik mani investor spoken tempt
bat nervou decis canada made base one could
argu favour result potenti support bat could greatest
watch movement imperi
although imperi exposur canada reason includ
given bat busi call imperi canada often assum imperi
busi mention media report basi neg headlin
around canada imperi tobacco canada own bat would
surpris imperi also see weak buy name movement easi
money view loss recov market realis impact
page
pleas see import disclosur inform page report
 stock specif catalyst -ve skew imb jt
addit industri theme catalyst impact perform certain
stock specif catalyst look
bat focu evid reduc risk contribut
evid contribut reduc risk global
argu key factor hold bat multipl back relat
pm lack convict reduc risk outlook seen trail pm
compani awar reason surpris encourag
outlin benefit us corpor tax would re-invest back
busi primarili reduc risk market also appear taken
recent rrp re-rat on-going perman talk invest
ambit growth enough view convinc market especi
light could consid soft near term rrp sale expect investor
day octob see discuss around market want see
actual contribut come number also keen see key metric
share convers level product roll new market pm
deliv area arguabl multipl seen support result
mind huge import therefor compani split
reduc risk contribut top line least year end result
bat split contribut market look see similar trend
pm stage roll comparison show
expect organ rrp contribut group sale bat chart
vs would suitabl compar period pm chart bat fall short
pm multipl could see pressur
wors case bat even split rrp contribut think
taken neg market
chart expect bat organ rrp contribut
chart actual pm organ rrp contribut
evid lorillard synergi us
anoth major sourc futur valu bat us tobacco busi ebit
within possibl deliveri synergi outlin reynold bought lorillard
remind reynold acquir lorillard primari ration deal
possibl synergi larg top line share acceler camel newport also
possibl deliveri outlin cost synergi
page
pleas see import disclosur inform page report
date littl evid deliveri synergi given us
larg part group profit give one would assum part premium bat
paid reynold reflect deliveri synergi think market
want see evid soon think multipl see support
doesnt multipl could see pressur
case market share recent nielsen data chart show sign
optimist certainli newport also small sign improv
camel recent pick us would suggest perhap reason stagnat
date stagnat mean lack acceler year one
integr lorillard portfolio year two bat bid came mean
littl incent reynold manag push initi
market want see continu recent improv newport
want see acceler camel especi brand come like
aggress altria invest
chart histor market share trend newport camel
subject cost save compani alreadi deliv usd
outlin front part deal alway hope could exceed
number especi brought game changer incent bonu employe
purpos avenu gain manag spoke past includ
procur synergi scale opportun leaf owe lorillard employ
updat evid cost save post realis usd
support could anoth possibl sourc encourag disappoint
market
reynold synergi possibl upgrad fulli integr
acquir reynold bat initi identifi cost save opportun
realis year believ may get upgrad number year
also could hear potenti revenu synergi opportun exampl
take newport us
imb recoveri price reduc risk move main watch-out
recoveri price key market question mark
despit final begin take share imperi abl hit top line
target due competit price activ number key market market
weigh russia uk franc make imperi profit
headlin price come compani say need
deliv hit top line target evid recoveri market
page
pleas see import disclosur inform page report
